Ptc Therapeutics (PTCT) Work In Process (2019 - 2026)

Ptc Therapeutics' Work In Process history runs 8 years deep, the most recent figure standing at $52.8 million for Q1 2026.

• In Q1 2026, Work In Process rose 304.07% year-over-year to $52.8 million; the TTM figure through Mar 2026 stood at $52.8 million (up 304.07% YoY), while the FY2025 annual figure was $55.7 million, up 355.84% from the prior year.
• Work In Process was $52.8 million for Q1 2026 at Ptc Therapeutics, down from $55.7 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $55.7 million in Q4 2025 to a low of $7.0 million in Q2 2022.
• Historically, Work In Process has averaged $22.9 million across 5 years, with a median of $20.9 million in 2023.
• Biggest YoY gain for Work In Process was 355.84% in 2025; the steepest drop was 41.09% in 2025.
• A 5-year view of Work In Process shows it stood at $14.1 million in 2022, then gained by 27.83% to $18.0 million in 2023, then plunged by 32.1% to $12.2 million in 2024, then jumped by 355.84% to $55.7 million in 2025, then decreased by 5.19% to $52.8 million in 2026.
• The last three Work In Process figures came in at $52.8 million (Q1 2026), $55.7 million (Q4 2025), and $41.8 million (Q3 2025), per Business Quant data.